Nuvini Group Renegotiates Earnout Liabilities with Founders, Reducing by 36%
Nuvini Group announced the renegotiation of earnout contingent liabilities with founders of previously acquired portfolio companies, resulting in a 36% reduction in these obligations. The restructuring significantly improves Nuvini's proforma debt-to-EBITDA ratio, positioning the Company to secure more favorable terms for private credit financing. This enhanced capital structure will support the payoff of existing obligations and fund new strategic acquisitions over the next 90 days. "This restructuring reflects our commitment to maintaining a disciplined and optimized capital structure as we continue executing our acquisition strategy," said Pierre Schurmann, CEO. "By proactively renegotiating these earnout obligations with our portfolio company founders, we have created significant financial flexibility that will enable us to access private credit markets on more attractive terms."
Trade with 70% Backtested Accuracy
Analyst Views on NVNI
About NVNI
About the author
Nuvini Welcomes AI Expert Phoebe Wang to Its Board of Directors
Appointment of Phoebe Wang: Nuvini Group Limited has appointed Phoebe Wang to its Board of Directors, effective November 14, 2025, bringing her extensive experience in AI and enterprise technology to the company.
Commitment to AI and Cloud Innovation: Wang's appointment aligns with Nuvini's recent partnership with Oracle, emphasizing the company's focus on integrating advanced AI and cloud capabilities to enhance its SaaS portfolio.
Strategic Goals: Nuvini aims to scale profitability and improve customer retention and operational efficiency through AI, with Wang's expertise expected to support these objectives.
Company Overview: Nuvini, headquartered in São Paulo, Brazil, is a leading acquirer of profitable B2B SaaS businesses in Latin America, focusing on creating value through strategic partnerships and operational expertise.
Nuvini Group Names Roberto Otero as CFO
New CFO Appointment: Nuvini Group Limited has appointed Roberto Otero as Chief Financial Officer, effective November 3.
Successor Details: Otero will replace Luiz Busnello, who will remain with the company as a board member after his transition from the CFO role.
Otero's Background: Prior to this appointment, Otero served as CFO of Eurofarma's International Operations, managing financial strategy and treasury across 23 countries.
Disclaimer: The views expressed in the article are those of the author and do not necessarily reflect the opinions of Nasdaq, Inc.
